AZR Conversion Disclosure
Davidson Matt · SEC Form 4 · Filed Nov 4, 2026
Conversion
Calculated transaction value
$0
Davidson Matt President And CEO
AZR
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
AZR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series A Preferred Stock on Common Stock
- Quantity / price
- 524.95 shares @ $0
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001213900-26-115985
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Azora Therapeutics, Inc. (de) AZR | Conversion | Nov 2, 2026 | Not reported |
| Azora Therapeutics, Inc. (de) AZR | Conversion | Nov 2, 2026 | Not reported |
| Azora Therapeutics, Inc. (de) AZR Current | Conversion | Nov 2, 2026 | $0 |
| Azora Therapeutics, Inc. (de) AZR | Conversion | Nov 2, 2026 | $0 |